[1] 朱雄增, 李小秋. 解读2008年恶性淋巴瘤WHO分类—B细胞淋巴瘤[J]. 临床与实验病理学杂志, 2010, 26(2): 125−130. DOI: 10.3969/j.issn.1001−7399.2010.02.001. Zhu XZ, Li XQ. Inerpretation of the 2008 WHO classification of malignant lymphoma—B celllymphoma[J]. J Clin Exp Pathol, 2010, 26(2): 125−130. DOI: 10.3969/j.issn.1001−7399.2010.02.001.
[2] Chukwueke UN, Nayak L. Central Nervous System Lymphoma[J]. Hematol/Oncol Clin North Am, 2019, 33(4): 597−611. DOI: 10.1016/j.hoc.2019.03.008.
[3] Fuentes-Raspall R, Solans M, Auñon-Sanz C, et al. Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994−2013)[J]. Clin Transl Oncol, 2018, 20(12): 1628−1630. DOI: 10.1007/s12094−018−1890−8.
[4] Suh CH, Kim HS, Park JE, et al. Primary Central Nervous System Lymphoma: Diagnostic Yield of Whole-Body CT and FDG PET/CT for Initial Systemic Imaging[J]. Radiology, 2019, 292(2): 440−446. DOI: 10.1148/radiol.2019190133.
[5] 吴慧. 原发性中枢神经系统淋巴瘤磁共振成像特征[J]. 影像研究与医学应用, 2019, 3(6): 80−81. DOI: 10.3969/j.issn.2096−3807.2019.06.049. Wu H. Magnetic resonance imaging features of primary central nervous system lymphoma[J]. J Imaging Res Med Appl, 2019, 3(6): 80−81. DOI: 10.3969/j.issn.2096−3807.2019.06.049.
[6] 曾雪明. 颅内肿瘤MRI分析(附667例报告)[D]. 南宁: 广西医科大学, 2010. DOI: 10.7666/d.y1683074. Zeng XM. MRI analysis of intracranial tumor (report of 667 cases)[D]. Nanning: Guangxi Medical University, 2010. DOI: 10.7666/d.y1683074.
[7] Yang YH, He MZ, Li T, et al. MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis[J]. Neurosurg Rev, 2019, 42(2): 185−195. DOI: 10.1007/s10143−017−0906−0.
[8] Zhang Q, Gao X, Wei GH, et al. Prognostic Value of MTV, SUV<sub>max</sub> and the T/N Ratio of PET/CT in Patients with Glioma: A Systematic Review and Meta-Analysis[J]. J Cancer, 2019, 10(7): 1707−1716. DOI: 10.7150/jca.28605.
[9] 杨柳. 18F-FDG PET/CT在原发性中枢神经系统淋巴瘤诊断中的应用价值[D]. 郑州: 郑州大学, 2019. Yang L. The value of 18F-FDG PET/CT in the diagnosis of central nervous system lymphoma[D]. Zhengzhou: Zhengzhou University, 2019.
[10] 白人驹, 张雪林. 医学影像诊断学[M]. 3版. 北京: 人民卫生出版社, 2001: 36−42. Bai RJ, Zhang XL. Medical imaging diagnostics[M]. 3rd ed. Beijing: People's Medical Publishing House, 2001: 36−42.
[11] 张晶晶, 刘保平, 阮翘, 等. 椎管内原发性弥漫性大B细胞淋巴瘤<sup>18</sup>F-FDG PET/CT显像一例[J]. 中华核医学与分子影像杂志, 2018, 38(5): 355−356. DOI: 10.3760/cma.j.issn.2095−2848.2018.05.012. Zhang JJ, Liu BP, Ruan Q, et al. <sup>18</sup>F-FDG PET/CT imaging in intra-spinal canal primary diffuse large B cell lymphoma: a case report[J]. Chin J Nucl Med Mol Imaging, 2018, 38(5): 355−356. DOI: 10.3760/cma.j.issn.2095−2848.2018.05.012.
[12] 崔向丽, 贾文清, 初君盛, 等. NCCN2009颅内原发淋巴瘤诊疗指南(译文)[J]. 中国神经肿瘤杂志, 2009, 7(4): 311−314. DOI: CNKI:SUN:CJNO.0.2009−04−018. Cui XL, Jia WQ, Chu JS, et al. NCCN2009 Guidelines for Diagnosis and Treatment of Intracranial Primary Lymphoma (Translation)[J]. Chin J Neuro-Oncol, 2009, 7(4): 311−314. DOI: CNKI:SUN:CJNO.0.2009−04−018.
[13] Sethi TK, Reddy NM. Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies[J]. Leuk Lymphoma, 2019, 60(1): 6−18. DOI: 10.1080/10428194.2018.1466296.
[14] Kong ZR, Jiang CD, Zhu RZ, et al. 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma[J/OL]. Neuroimage Clin, 2019, 23: 101912[2019-10-28]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702330. DOI: 10.1016/j.nicl.2019.101912.
[15] Jara H. Primary Central Nervous System Lymphoma: Lessons and Opportunities from 2 Decades of CT and PET/CT[J]. Radiology, 2019, 292(2): 447−448. DOI: 10.1148/radiol.2019191147.
[16] Liu DL, Kong ZR, Wang YK, et al. Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on <sup>18</sup>F-FDG-PET[J]. Interdiscip Sci: Comput Life Sci, 2019, 11(2): 300−306. DOI: 10.1007/s12539−019−00333−y.